Control in progression of a malignant lesion from onset to metastasis, utilizing an immunogenic oncofetal protein that characterizes and can destroy the lesion
system that the malignant growth, while containing immunogenic protein, express it at levels far below what is required for recognition by the hosts immunocytes. Antigen preparation for use in clinical ... lesions…

